The Food and Drug Administration is phasing out the use of petroleum-based synthetic dyes by the end of 2026 - a change that ...

The rolls were sold at the retail level in Pennsylvania, California, Connecticut, Maryland, Delaware, and Ohio, according to ...

Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...

In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering will launch this week ...

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with ...

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.

The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...

You have to watch your diet with MAOIs. However, I eat an avocado every day and frequently have cheddar cheese. I don’t care ...

As pressure grows to get artificial colors out of the U.S. food supply, the shift may well start at Abby Tampow’s laboratory ...

Regeneron missed Wall Street estimates for first-quarter results on Tuesday, hurt by waning demand for its blockbuster eye ...

Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...

Novo Nordisk said on Tuesday it was partnering with telehealth firms Hims & Hers , Ro and LifeMD to sell branded versions of ...